Identification of secreted proteins that reflect autophagy dynamics within tumor cells

Adam A Kraya1, Shengfu Piao, Xiaowei Xu

  • 1a Center for Systems and Computational Biology; The Wistar Institute ; Philadelphia , PA USA.

Autophagy
|December 9, 2014
PubMed

Insights

Autophagy, a cellular process, influences melanoma tumor growth and microenvironment. Researchers identified specific secreted proteins that can measure tumor autophagy levels in patients, aiding cancer therapy development.

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • Macroautophagy is a key survival mechanism for tumor cells and a target for cancer therapies.
  • Autophagy's role in secretion and its impact on the tumor microenvironment are not well understood.
  • Current methods for measuring tumor autophagy in clinical settings are suboptimal.

Purpose of the Study:

  • To identify shed proteins associated with autophagy levels in melanoma.
  • To explore the potential of these secreted proteins as biomarkers for tumor autophagy.
  • To investigate the link between autophagy-mediated secretion and the tumor microenvironment.

Main Methods:

  • Quantitative proteomics was used to compare the secretomes of low- and high-autophagy melanoma cells in 3D culture.
  • Candidate biomarkers were validated in independent melanoma cell lines and in response to autophagy modulation (tat-BECN1 peptide, ATG7 silencing).
  • Secreted protein levels were measured in serum from metastatic melanoma patients with varying tumor autophagy levels.

Main Results:

  • Five candidate autophagy biomarkers were identified: IL1B, CXCL8, LIF, FAM3C, and DKK3.
  • These proteins were elevated in high-autophagy melanoma cells and their secretion levels correlated with autophagy dynamics.
  • Serum levels of these proteins were higher in metastatic melanoma patients with high tumor autophagy.

Conclusions:

  • Autophagy-related secretion influences the tumor microenvironment in melanoma.
  • Measured autophagy-associated secreted proteins in plasma can serve as surrogates for intracellular autophagy.
  • These findings offer potential new biomarkers for assessing tumor autophagy and guiding antineoplastic therapies.

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
6.5K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
10.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K